Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.2M Buy
351,131
+223,444
+175% +$25.8M 0.01% 1172
2025
Q4
$13.4M Sell
127,687
-523,397
-80% -$49.1M ﹤0.01% 1979
2025
Q3
$54.6M Buy
651,084
+642,719
+7,683% +$52.9M 0.01% 909
2025
Q2
$662K Sell
8,365
-371,327
-98% -$29.5M ﹤0.01% 6413
2025
Q1
$34.1M Sell
379,692
-22,040
-5% -$2.06M 0.01% 913
2024
Q4
$40M Buy
401,732
+239,324
+147% +$24.7M 0.01% 816
2024
Q3
$18.4M Sell
162,408
-2,272,016
-93% -$270M ﹤0.01% 1305
2024
Q2
$301M Buy
2,434,424
+841,959
+53% +$108M 0.07% 147
2024
Q1
$210M Buy
1,592,465
+1,028,701
+182% +$127M 0.04% 206
2023
Q4
$61.5M Buy
563,764
+190,342
+51% +$19.8M 0.02% 587
2023
Q3
$38.4M Buy
373,422
+18,245
+5% +$1.97M 0.01% 687
2023
Q2
$41M Sell
355,177
-381,746
-52% -$43.3M 0.01% 709
2023
Q1
$78.4M Buy
736,923
+495,063
+205% +$53.4M 0.03% 364
2022
Q4
$26.8M Buy
241,860
+131,023
+118% +$13.4M 0.01% 820
2022
Q3
$9.55M Sell
110,837
-33,264
-23% -$2.97M ﹤0.01% 1745
2022
Q2
$13.1M Sell
144,101
-344,036
-70% -$30.5M 0.01% 1456
2022
Q1
$40.1M Sell
488,137
-99,931
-17% -$7.88M 0.01% 788
2021
Q4
$45.1M Sell
588,068
-1,074,445
-65% -$85.6M 0.01% 697
2021
Q3
$125M Buy
1,662,513
+557,899
+51% +$42.4M 0.04% 286
2021
Q2
$85.9M Buy
1,104,614
+82,480
+8% +$6.13M 0.03% 353
2021
Q1
$75.2M Buy
1,022,134
+578,187
+130% +$42.6M 0.04% 357
2020
Q4
$34.7M Buy
443,947
+210,824
+90% +$16.1M 0.02% 575
2020
Q3
$18.5M Buy
233,123
+67,854
+41% +$5.31M 0.01% 825
2020
Q2
$12.2M Buy
165,269
+110,090
+200% +$8.29M 0.01% 1051
2020
Q1
$4.05M Sell
55,179
-25,057
-31% -$1.97M ﹤0.01% 1349
2019
Q4
$6.96M Sell
80,236
-63,671
-44% -$5.23M 0.01% 841
2019
Q3
$11.6M Buy
143,907
+75,070
+109% +$6.02M 0.02% 534
2019
Q2
$5.51M Sell
68,837
-426,454
-86% -$32.7M 0.01% 979
2019
Q1
$39.3M Buy
495,291
+419,924
+557% +$31.4M 0.06% 235
2018
Q4
$5.5M Sell
75,367
-40,478
-35% -$2.86M 0.01% 889
2018
Q3
$7.84M Sell
115,845
-12,078
-9% -$769K 0.02% 754
2018
Q2
$7.41M Sell
127,923
-24,530
-16% -$1.38M 0.02% 779
2018
Q1
$7.92M Sell
152,453
-54,580
-26% -$2.95M 0.02% 655
2017
Q4
$11.1M Sell
207,033
-283,447
-58% -$15.7M 0.03% 472
2017
Q3
$30M Buy
490,480
+438,865
+850% +$26.6M 0.1% 190
2017
Q2
$3.16M Buy
51,615
+43,328
+523% +$2.64M 0.01% 1090
2017
Q1
$502K Sell
8,287
-79,640
-91% -$4.83M ﹤0.01% 2870
2016
Q4
$4.94M Sell
87,927
-105,730
-55% -$6.19M 0.02% 672
2016
Q3
$11.5M Buy
193,657
+174,034
+887% +$10.2M 0.06% 277
2016
Q2
$1.08M Sell
19,623
-13,001
-40% -$692K 0.01% 1898
2016
Q1
$1.65M Sell
32,624
-11,658
-26% -$571K 0.01% 1365
2015
Q4
$2.23M Buy
44,282
+20,483
+86% +$1.03M 0.01% 970
2015
Q3
$1.12M Buy
23,799
+1,876
+9% +$99.7K 0.01% 1532
2015
Q2
$1.19M Buy
21,923
+293
+1% +$16.4K 0.01% 1396
2015
Q1
$1.19M Buy
21,630
+16,023
+286% +$907K 0.01% 1249
2014
Q4
$304K Sell
5,607
-3,812
-40% -$212K ﹤0.01% 1876
2014
Q3
$533K Sell
9,419
-90,455
-91% -$5.08M 0.01% 1382
2014
Q2
$5.51M Buy
99,874
+92,633
+1,279% +$5.05M 0.07% 238
2014
Q1
$392K Sell
7,241
-335,071
-98% -$17.4M ﹤0.01% 1772
2013
Q4
$16.3M Buy
342,312
+303,086
+773% +$13.9M 0.23% 74
2013
Q3
$1.78M Buy
39,226
+26,059
+198% +$1.19M 0.02% 664
2013
Q2
$584K Buy
+13,167
New +$588K 0.01% 1306

Other funds holding MRK

Jane Street's MRK Position: Q1 2026 in Review

Jane Street increased its Merck (MRK) stake by 175% in Q1 2026, buying an estimated $25.8M and bringing the position to 351,131 shares worth $42.2M. The position accounts for 0.01% of the portfolio, ranked #1172.

Jane Street first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $301M in Q2 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Jane Street held 351,131 shares of Merck worth $42.2M as of Q1 2026.
  • Jane Street bought 223,444 Merck shares in Q1 2026, an estimated $25.8M.
  • Merck made up 0.01% of Jane Street's portfolio in Q1 2026, its #1172 holding.
  • Jane Street first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Jane Street's Merck position peaked at $301M in Q2 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.